ETRI, South Korea’s leading government-funded research institute, is establishing itself as a key research entity for ...

The collaboration leverages BostonGene's foundation model for tumor and immune biology to deliver predictive insights on patient-level safety and efficacy outcomes in early clinical trials.

H2OVL Mississippi 0.8B Model Surpasses Leading Small Vision Language Models (SVLMs) and Impressively Outperforms Larger State-of-the-Art Vision Language Models (VLMs) in OCR Benchmarks for Text ...

BostonGene, the developer of an AI foundation model for tumor and immune biology, has entered a strategic collaboration with ...

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced multi-year, strategic collaborations ...

The AI industry has long been dominated by text-based large language models (LLMs), but the future lies beyond the written word. Multimodal AI represents the next major wave in artificial intelligence ...

Tempus AI has signed a three-way deal with AstraZeneca and Pathos AI to construct a data-based oncology model that could ultimately be used to develop new cancer drugs. Tempus will use its “vast ...

SEATTLE--(BUSINESS WIRE)--Ai2 (The Allen Institute for AI) today announced the OlmoEarth Platform, the first open, end-to-end solution that transforms global satellite and sensor data into real-time ...

Five consortia participating in Korea’s national artificial intelligence (AI) foundation model project unveiled their models ...

In 2025, large language models moved beyond benchmarks to efficiency, reliability, and integration, reshaping how AI is ...